长春高新：子公司GenSci141软膏境内生产药品注册临床试验申请获得批准

Core Viewpoint - The announcement indicates that the subsidiary of Changchun High-tech, Jinsai Pharmaceutical, has received approval from the National Medical Products Administration for the clinical trial of GenSci141 ointment, a product developed by the company [1] Group 1 - Jinsai Pharmaceutical has obtained the Clinical Trial Approval Notice for GenSci141 ointment [1] - GenSci141 ointment is a dihydrotestosterone ointment classified as a chemical drug of categories 2.2 and 2.4 [1]